Literature DB >> 21412069

Similarities and differences between intraductal papillary tumors of the bile duct with and without macroscopically visible mucin secretion.

Masayuki Ohtsuka1, Fumio Kimura, Hiroaki Shimizu, Hiroyuki Yoshidome, Atsushi Kato, Hideyuki Yoshitomi, Katsunori Furukawa, Dan Takeuchi, Tsukasa Takayashiki, Kosuke Suda, Shigetsugu Takano, Yoichiro Kondo, Masaru Miyazaki.   

Abstract

Intraductal papillary neoplasms of the bile duct (IPNB) have been recently proposed as the biliary counterpart of intraductal papillary mucinous neoplasms of the pancreas (IPMN-P). However, in contrast to IPMN-P, IPNB include a considerable number of the tumors without macroscopically visible mucin secretion. Here we report the similarities and differences between IPNB with and without macroscopically visible mucin secretion (IPNB-M and IPNB-NM). Surgically resected 27 consecutive cases with IPNB were divided into IPNB-M (n=10) and IPNB-NM (n=17), and their clinicopathologic features were examined. Clinically, both tumors were similar. Pathologically, the most frequent histopathologic types were pancreatobiliary in IPNB-NM and intestinal in IPNB-M. Various degrees of cytoarchitectural atypia within the same tumor were exhibited in 8 IPNB-M, but only 3 in IPNB-NM. Although the tumor size was similar, 9 IPNB-NM were invasive carcinoma, whereas all but 1 IPNB-M with carcinoma were in situ or minimally invasive. Immunohistochemically, positive MUC2 expression was significantly more frequent in IPNB-M than in IPNB-NM, whereas MUC1 tended to be more frequently expressed in IPNB-NM compared with IPNB-M. Among IPNB-NM with positive MUC1 expression, 3 had negative MUC2 and MUC5AC expressions. These tumors showed a tubulopapillary growth with uniform degree of cytoarchitectural atypia. All IPNB-M were negative for p53, and the frequency of positive p53 protein in IPNB-NM was at the middle level of that in IPNB-M and nonpapillary cholangiocarcinoma. In conclusion, IPNB-M showed striking similarities to IPMN-P, but IPNB-NM contained heterogeneous disease groups.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21412069     DOI: 10.1097/PAS.0b013e3182103f36

Source DB:  PubMed          Journal:  Am J Surg Pathol        ISSN: 0147-5185            Impact factor:   6.394


  34 in total

1.  CT imaging comparison between intraductal papillary neoplasms of the bile duct and papillary cholangiocarcinomas.

Authors:  Takahiro Komori; Dai Inoue; Yoh Zen; Norihide Yoneda; Azusa Kitao; Kazuto Kozaka; Akira Yokka; Fumihito Toshima; Takashi Matsubara; Satoshi Kobayashi; Toshifumi Gabata
Journal:  Eur Radiol       Date:  2018-12-05       Impact factor: 5.315

2.  Simultaneous intraductal papillary neoplasms of the bile duct and pancreas treated with chemoradiotherapy.

Authors:  Roberto Valente; Gabriele Capurso; Paola Pierantognetti; Elsa Iannicelli; Matteo Piciucchi; Adriana Romiti; Paolo Mercantini; Alberto Larghi; Giulia Francesca Federici; Viola Barucca; Maria Falchetto Osti; Emilio Di Giulio; Vincenzo Ziparo; Gianfranco Delle Fave
Journal:  World J Gastrointest Oncol       Date:  2012-02-15

3.  Intraductal papillary neoplasm of the bile duct, gastric type, arising in the intrapancreatic common bile duct could progress to colloid carcinoma: report of a case.

Authors:  Shogo Tajima; Akihiko Ohata; Kenji Koda; Yasuhiko Maruyama
Journal:  Int J Clin Exp Pathol       Date:  2015-05-01

4.  Clinicopathological significance of mucin production in patients with papillary cholangiocarcinoma.

Authors:  Shunsuke Onoe; Yoshie Shimoyama; Tomoki Ebata; Yukihiro Yokoyama; Tsuyoshi Igami; Gen Sugawara; Takashi Mizuno; Shigeo Nakamura; Masato Nagino
Journal:  World J Surg       Date:  2015-05       Impact factor: 3.352

5.  Morphological classification of intraductal papillary neoplasm of the bile duct.

Authors:  Shihong Ying; Mingliang Ying; Wenjie Liang; Zhaoming Wang; Qidong Wang; Feng Chen; Wenbo Xiao
Journal:  Eur Radiol       Date:  2017-11-14       Impact factor: 5.315

6.  Biliary tract intraductal papillary mucinous neoplasm: report of 19 cases.

Authors:  Xing Wang; Yun-Qiang Cai; Yong-Hua Chen; Xu-Bao Liu
Journal:  World J Gastroenterol       Date:  2015-04-14       Impact factor: 5.742

7.  Clinicopathological Features and Long-Term Outcomes of Intraductal Papillary Neoplasms of the Intrahepatic Bile Duct.

Authors:  Wan-Joon Kim; Shin Hwang; Yong-Joo Lee; Ki-Hun Kim; Kwang-Min Park; Chul-Soo Ahn; Deok-Bog Moon; Tae-Yong Ha; Gi-Won Song; Dong-Hwan Jung; Gil-Chun Park; Myeong-Hwan Kim; Sung-Koo Lee; Dong Wan Seo; Do Hyun Park; Sang Soo Lee; Sung-Gyu Lee
Journal:  J Gastrointest Surg       Date:  2016-02-12       Impact factor: 3.452

Review 8.  [Precursor lesions of pancreatobiliary cancer].

Authors:  B Sipos; T Henopp
Journal:  Pathologe       Date:  2011-11       Impact factor: 1.011

9.  Clinicopathological features of the intraductal papillary neoplasms of the intrahepatic bile duct.

Authors:  Gi-Woong Jang; Shin Hwang; Yong-Joo Lee; Ki-Hun Kim; Kwang-Min Park; Chul-Soo Ahn; Deok-Bog Moon; Tae-Yong Ha; Gi-Won Song; Dong-Hwan Jung; Gil-Chun Park; Sung-Gyu Lee
Journal:  Korean J Hepatobiliary Pancreat Surg       Date:  2012-11-30

10.  Pathological aspects of so called "hilar cholangiocarcinoma".

Authors:  Víctor M Castellano-Megías; Carolina Ibarrola-de Andrés; Francisco Colina-Ruizdelgado
Journal:  World J Gastrointest Oncol       Date:  2013-07-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.